{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:19:11Z","timestamp":1777807151851,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20241181"],"award-info":[{"award-number":["BK20241181"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221431"],"award-info":[{"award-number":["BK20221431"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017547","name":"Jiangsu Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.imlet.2026.107137","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:07:50Z","timestamp":1767629270000},"page":"107137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Escherichia coli J5-derived OMVs with hypoendotoxic LPS: Potential boosters of T-cell immunity and IL-17 production for enhanced vaccine efficacy"],"prefix":"10.1016","volume":"279","author":[{"given":"Jiawen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhang","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0001","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1080\/21645515.2016.1219003","article-title":"Vaccine adjuvants: why and how","volume":"12","author":"Christensen","year":"2016","journal-title":"Hum. Vacc. Immunother."},{"issue":"12","key":"10.1016\/j.imlet.2026.107137_bib0002","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.tim.2023.05.010","article-title":"Bacterial extracellular vesicles: an emerging avenue to tackle diseases","volume":"31","author":"Xie","year":"2023","journal-title":"Trends. Microbiol."},{"issue":"4","key":"10.1016\/j.imlet.2026.107137_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/mmbr.00032-22","article-title":"Outer membrane vesicles: biogenesis, functions, and issues","volume":"86","author":"Juodeikis","year":"2022","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2026.107137_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01707-21","article-title":"Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance","volume":"12","author":"Zhu","year":"2021","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.imlet.2026.107137_bib0005","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/hv.24129","article-title":"Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future","volume":"9","author":"Holst","year":"2013","journal-title":"Hum. Vaccin. ImmunOther"},{"issue":"1","key":"10.1016\/j.imlet.2026.107137_bib0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13578-024-01207-7","article-title":"Exploiting bacterial-origin immunostimulants for improved vaccination and immunotherapy: current insights and future directions","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci."},{"key":"10.1016\/j.imlet.2026.107137_bib0007","first-page":"393","article-title":"R. Untersuchungen uber das Choleragift","volume":"11","author":"Line Pfeiffer","year":"1892","journal-title":"Med. Microbiol. Immunol."},{"issue":"5831","key":"10.1016\/j.imlet.2026.107137_bib0008","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.imlet.2026.107137_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1029146","article-title":"Outer membrane vesicles: a bacterial-derived vaccination system","volume":"13","author":"Lieberman","year":"2022","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0010","first-page":"1271","article-title":"Multi-immunogenic outer membrane vesicles derived from a MsbB-deficient Salmonella enterica serovar typhimurium mutant","volume":"19","author":"Lee","year":"2009","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.imlet.2026.107137_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fcimb.2016.00148","article-title":"Protective immunity elicited by oral immunization of mice with Salmonella enterica serovar Typhimurium Braun lipoprotein (Lpp) and acetyltransferase (MsbB) mutants","volume":"6","author":"Erova","year":"2016","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.imlet.2026.107137_bib0012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3168\/jds.S0022-0302(92)77741-8","article-title":"Field trial to determine efficacy of an Escherichia coli J5 mastitis vaccine","volume":"75","author":"Hogan","year":"1992","journal-title":"J. Dairy. Sci."},{"issue":"3\u20135","key":"10.1016\/j.imlet.2026.107137_bib0013","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0171-2985(11)80357-8","article-title":"Immunotherapy of endotoxemia and septicemia","volume":"187","author":"Baumgartner","year":"1993","journal-title":"Immunobiology"},{"issue":"1\u20132","key":"10.1016\/j.imlet.2026.107137_bib0014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vetmic.2008.05.012","article-title":"Identification of a bovine mastitis Escherichia coli subset","volume":"132","author":"Blum","year":"2008","journal-title":"Vet. Microbiol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107137_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.01227-20","article-title":"Shielding effect of Escherichia coli O-antigen polysaccharide on J5-induced cross-reactive antibodies","volume":"6","author":"Rainard","year":"2021","journal-title":"mSphere"},{"issue":"7","key":"10.1016\/j.imlet.2026.107137_bib0016","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.3168\/jds.2019-17799","article-title":"Short communication: J-5 Escherichia coli vaccination does not influence severity of an Escherichia coli intramammary challenge in primiparous cows","volume":"103","author":"Vangroenweghe","year":"2020","journal-title":"J. Dairy. Sci."},{"key":"10.1016\/j.imlet.2026.107137_bib0017","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/319297","article-title":"Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis","volume":"183","author":"Cross","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.imlet.2026.107137_bib0018","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104926","article-title":"Direct binding of polymeric GBP1 to LPS disrupts bacterial cell envelope functions","volume":"39","author":"Kutsch","year":"2020","journal-title":"EMBO J."},{"issue":"7","key":"10.1016\/j.imlet.2026.107137_bib0019","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.3168\/jds.2021-20122","article-title":"Role of long polar fimbriae type 1 and 2 in pathogenesis of mammary pathogenic Escherichia coli","volume":"104","author":"Zhou","year":"2021","journal-title":"J. Dairy. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2026.107137_bib0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.chembiol.2024.01.002","article-title":"Anti-tumor immunotherapy using engineered bacterial outer membrane vesicles fused to lysosome-targeting chimeras mediated by transferrin receptor","volume":"31","author":"Su","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.imlet.2026.107137_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112470","article-title":"Development of Hsp90 inhibitor to regulate cytokine storms in excessive delayed- and acute inflammation","volume":"137","author":"Sim","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0022","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.vaccine.2024.03.033","article-title":"Lymphatic distribution considerations for subunit vaccine design and development","volume":"42","author":"Hartmeier","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0023","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.3168\/jds.S0022-0302(00)75112-5","article-title":"A comparison of two commercially available Escherichia coli J5 vaccines against E. coli intramammary challenge","volume":"83","author":"Tomita","year":"2000","journal-title":"J. Dairy. Sci."},{"key":"10.1016\/j.imlet.2026.107137_bib0024","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.imlet.2026.107137_bib0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107137_bib0026","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0027","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107137_bib0028","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2026.107137_bib0029","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2026.107137_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"26","key":"10.1016\/j.imlet.2026.107137_bib0031","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.1182\/blood-2011-01-329185","article-title":"Langerhans cells regulate cutaneous injury by licensing CD8 effector cells recruited to the skin","volume":"117","author":"Bennett","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2026.107137_bib0032","first-page":"75","article-title":"Adjuvants and adjuvanticity","volume":"10","author":"Tizard","year":"2020","journal-title":"Vaccines Vet."},{"issue":"3","key":"10.1016\/j.imlet.2026.107137_bib0033","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(01)00455-X","article-title":"Regulation of T cell immunity by dendritic cells","volume":"106","author":"Lanzavecchia","year":"2001","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.imlet.2026.107137_bib0034","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat. Immunol."},{"issue":"33","key":"10.1016\/j.imlet.2026.107137_bib0035","doi-asserted-by":"crossref","first-page":"10114","DOI":"10.1021\/acs.nanolett.4c02196","article-title":"Uniform polymeric nanovaccine platform for improving the availability and efficacy of neoantigen peptides","volume":"24","author":"Chen","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.imlet.2026.107137_bib0036","article-title":"Interleukin-1 as innate mediator of T cell immunity","volume":"11","author":"Van Den Eeckhout","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2026.107137_bib0037","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1128\/IAI.00398-10","article-title":"Mucosal immunization with outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility","volume":"78","author":"Bishop","year":"2010","journal-title":"Infect. Immun."},{"issue":"97","key":"10.1016\/j.imlet.2026.107137_bib0038","article-title":"RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2","volume":"23","author":"Feng","year":"2025","journal-title":"J. Nanobiotechn."},{"key":"10.1016\/j.imlet.2026.107137_bib0039","article-title":"A core glycolipid vaccine elicits cross-reactive antibodies against Salmonella spp. And protects against invasive nontyphoidal Salmonella disease in mice","author":"Baliban","year":"2024","journal-title":"J. Infect. Dis."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:48:51Z","timestamp":1777495731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826000106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"alternative-id":["S0165247826000106"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107137","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escherichia coli J5-derived OMVs with hypoendotoxic LPS: Potential boosters of T-cell immunity and IL-17 production for enhanced vaccine efficacy","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107137"}}